Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000624636 | SCV000742542 | uncertain significance | Inborn genetic diseases | 2017-05-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002233902 | SCV002511896 | uncertain significance | not specified | 2022-04-14 | criteria provided, single submitter | clinical testing | Variant summary: HUWE1 c.6149G>A (p.Arg2050Gln) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 1.9e-05 in 205237 control chromosomes, including one hemizygote (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.6149G>A in individuals affected with Intellectual Disability, X-Linked Syndromic, Turner Type and no experimental evidence demonstrating its impact on protein function have been reported. One ClinVar submitter has assessed the variant since 2014: the variant was classified as of uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Labcorp Genetics |
RCV003718271 | SCV004506846 | likely benign | not provided | 2022-12-05 | criteria provided, single submitter | clinical testing |